Waterhouse, M.; Pennisi, S.; Pfeifer, D.; Scherer, F.; Zeiser, R.; Duyster, J.; Bertz, H.; Finke, J.; Duque-Afonso, J.
Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell Transplantation. Cancers 2022, 14, 3307.
https://doi.org/10.3390/cancers14143307
AMA Style
Waterhouse M, Pennisi S, Pfeifer D, Scherer F, Zeiser R, Duyster J, Bertz H, Finke J, Duque-Afonso J.
Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell Transplantation. Cancers. 2022; 14(14):3307.
https://doi.org/10.3390/cancers14143307
Chicago/Turabian Style
Waterhouse, Miguel, Sandra Pennisi, Dietmar Pfeifer, Florian Scherer, Robert Zeiser, Justus Duyster, Hartmut Bertz, Jürgen Finke, and Jesús Duque-Afonso.
2022. "Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell Transplantation" Cancers 14, no. 14: 3307.
https://doi.org/10.3390/cancers14143307
APA Style
Waterhouse, M., Pennisi, S., Pfeifer, D., Scherer, F., Zeiser, R., Duyster, J., Bertz, H., Finke, J., & Duque-Afonso, J.
(2022). Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell Transplantation. Cancers, 14(14), 3307.
https://doi.org/10.3390/cancers14143307